Thus, synergistically enhanced tumor cell killing was obtained by concomitant engagement of either NKp30 and NKG2D or NKp80 and NKG2D, whereas co-ligation of NKp30 and NKp80 resulted in additive effects. Here, KLRK1 is linked to neoplasm.